Health Invest Finland is on a mission to revolutionize patient care by harnessing the power of real-time health information technology. At the core of our strategy is My+Care™, an AI-driven mHealth platform that seamlessly integrates wearable biosensors, mobile applications and big-data analytics into existing hospital and home-care workflows. By detecting early warning signs of clinical deterioration, optimizing resource allocation, and empowering patients with actionable insights, we aim to reduce avoidable complications, improve outcomes and relieve pressure on strained healthcare systems.
Our Vision and Commitment
We believe that everyone deserves timely, personalized care—regardless of location or circumstance. To achieve this, Health Invest Finland combines decades of clinical expertise with cutting-edge engineering to deliver solutions that scale across geographies and care settings. Our vision is to close the gap between the first subtle signs of illness and definitive clinical intervention, transforming reactive medicine into proactive, predictive care.
My+Care™: End-to-End mHealth Platform
My+Care™ brings together three converging technology trends:
- Physiological Sensor Technology: Wearables capture continuous, medical-grade data on heart rate (PPG), movement (accelerometry), skin conductance and more.
- Smart Mobile Applications: Patient-facing apps record symptoms, deliver questionnaires (PROMs), coach adherence and enable instant two-way communication with care teams.
- Real-Time Big-Data Analytics: Federated machine-learning pipelines on AWS/Azure analyze streams of biosensor and patient-reported data to predict events such as atrial fibrillation, COPD exacerbations or sepsis up to 12 hours before clinical onset.
Impact on Care Delivery
By harnessing My+Care™, healthcare organizations achieve:
- Early Detection & Intervention: Automated algorithms reduce time to diagnosis, cutting 30-day readmissions for heart failure by up to 15% in pilot studies.
- Optimized Workflows: Intelligent triage engines lower false alarms by over 40%, allowing nurses and physicians to focus on truly urgent cases.
- Enhanced Patient Engagement: Interactive coaching and real-time feedback loops improve medication adherence, self-management and satisfaction.
- Robust Evidence Generation: Real-world data fuels continuous platform refinement, supports regulatory filings (CE-marking as a Class IIa medical device under EU MDR 2017/745) and informs health-economic models.
Addressing Demographic Challenges
Europe faces a looming demographic shift: between 2010 and 2050, the EU’s working-age population will shrink by 48 million (–16%), while the elderly cohort grows by 58 million (+77%). Fewer caregivers must support an aging population with rising chronic-care needs. My+Care™ directly addresses this challenge by enabling scalable remote monitoring—amplifying clinician capacity without compromising safety or quality.
Investment Case
Health Invest Finland invites stakeholders to join us in scaling My+Care™ globally. Our platform delivers measurable ROI through:
- Resource Efficiency: AI-driven personnel scheduling and real-time location tracking ensure optimal deployment in emergencies.
- Cost Reduction: Preventing avoidable hospitalizations and complications lowers operational expenses and frees capacity.
- Market Differentiation: Health systems adopting proactive, data-driven care position themselves as leaders in value-based medicine.
Looking Ahead
As My+Care™ expands across the Nordics, Asia and beyond, Health Invest Finland remains dedicated to continuous innovation, rigorous clinical validation and patient-centered design. We are committed to forging partnerships with healthcare providers, technology leaders and policymakers to ensure that every person has access to safer, smarter and more compassionate care.
